Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00476697 · ClinicalTrials.gov registry record · NA
UVA1 Light for Scleroderma and Similar Conditions
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00476697 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 23 participants.
The verdict
NCT00476697, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this investigation is to evaluate the effectiveness of high-dose UVA1 irradiation in the treatment of fibrosing conditions of the skin, e.g., keloid (a thick scar from growth of fibrous tissue), scleroderma (deposits of fibrous tissue in the skin) and acne keloidalis nuchae (keloids on the back of the neck or hairline) old burn scars, granuloma annulare or other similar skin conditions. This UVA1 dosing schedule has been used successfully in Germany for various skin diseases, such as the above mentioned scleroderma.
Interventions
- DEVICE German manufactured UVA1 emitting light system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 1997-01 |
| Est. Completion | 2003-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00476697
The ClinicalTrials.gov registry entry for NCT00476697 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which German manufactured UVA1 emitting light system is the first listed.
NCT00476697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00476697 about?
NCT00476697 is a clinical study titled "UVA1 Light for Scleroderma and Similar Conditions". The purpose of this investigation is to evaluate the effectiveness of high-dose UVA1 irradiation in the treatment of fibrosing conditions of the skin, e.g., keloid (a thick scar from growth of fibrous tissue), scleroderma (deposits of fibrous tissue in the skin) and acne keloidalis nuchae (keloids o...
What is the current status of trial NCT00476697?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 1997-01. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00476697?
The interventions under investigation include: German manufactured UVA1 emitting light system (DEVICE).
Who is sponsoring clinical trial NCT00476697?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.